| scholarly article | Q13442814 |
| P50 | author | Jill S. Barnholtz-Sloan | Q61089748 |
| P2093 | author name string | James Lutterbaugh | |
| Sanford D Markowitz | |||
| Yanwen Chen | |||
| Lakshmeswari Ravi | |||
| Amitabh Chak | |||
| Joseph E Willis | |||
| Rom S Leidner | |||
| Helen Moinova | |||
| P2860 | cites work | Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis | Q24602426 |
| Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study | Q24609281 | ||
| Field defects in progression to gastrointestinal tract cancers | Q24653877 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology | Q28274937 | ||
| Analysis of fecal DNA methylation to detect gastrointestinal neoplasia | Q30491000 | ||
| Sensitive digital quantification of DNA methylation in clinical samples | Q33761814 | ||
| Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus | Q34761782 | ||
| Global burden of cancer. | Q36014891 | ||
| Next-generation stool DNA testing: expanding the scope | Q37451944 | ||
| Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity | Q37568033 | ||
| DNA methylation markers in colorectal cancer | Q37687919 | ||
| Developing a nonendoscopic screening test for Barrett's esophagus | Q37887000 | ||
| Highly methylated genes in colorectal neoplasia: implications for screening | Q38295200 | ||
| Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples | Q39639960 | ||
| Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection | Q40306062 | ||
| Esophageal adenocarcinoma incidence: are we reaching the peak? | Q45001265 | ||
| Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic. | Q53679889 | ||
| Improved fecal DNA test for colorectal cancer screening. | Q54567825 | ||
| Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. | Q54650748 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| A simplified, noninvasive stool DNA test for colorectal cancer detection | Q81900521 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 594-600 | |
| P577 | publication date | 2012-02-07 | |
| P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
| P1476 | title | Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies | |
| P478 | volume | 21 |
| Q55658806 | A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma. |
| Q38741177 | An In Vitro Model for the Study of the Macrophage Response Upon Trichophyton rubrum Challenge. |
| Q90634262 | Cytoskeletal and extracellular matrix proteins as markers for metastatic triple negative breast cancer |
| Q36503180 | DNA hypermethylation of the vimentin gene inversely correlates with vimentin expression in intestinal- and diffuse-type gastric cancer |
| Q40193200 | Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma |
| Q35666522 | Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma |
| Q30826635 | Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use. |
| Q36725997 | Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma |
| Q47561735 | Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus |
| Q30685917 | Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus |
| Q88687901 | Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus |
| Q35004277 | Proteomic analysis of meningiomas |
| Q94602422 | Recent advances in understanding and preventing oesophageal cancer |
| Q91786195 | Role of TFF3 as an adjunct in the diagnosis of Barrett's esophagus using a minimally invasive esophageal sampling device-The CytospongeTM |
| Q91958923 | Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer |
| Q42065620 | Stool DNA testing for cancer surveillance in inflammatory bowel disease: an early view |
| Q37406537 | Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease |
| Q26852061 | Surgery in the era of the 'omics revolution |
| Q38718420 | TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer |
| Q31152739 | The CO-Regulation Database (CORD): a tool to identify coordinately expressed genes |
| Q34776216 | The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers |
| Q57094794 | Young Adult Cancer: Influence of the Obesity Pandemic |
Search more.